Nanohexaconazole: synthesis, characterisation and efficacy of a novel fungicidal nanodispersion
- PMID: 30104464
- PMCID: PMC8676510
- DOI: 10.1049/iet-nbt.2018.0041
Nanohexaconazole: synthesis, characterisation and efficacy of a novel fungicidal nanodispersion
Abstract
Here, the authors describe a simple method to formulate the nanodispersion of hexaconazole (hexa); henceforth, referred to as nanohexaconazole (N-hexa) that is water soluble and effective against several species of Aspergillus. Size and shape of the prepared nanocomposite was determined with high-resolution transmission electron microscopy and field-emission scanning electron microscopy. Nanohexaconazole structure was further confirmed by Fourier-transform infrared spectroscopy and gas chromatography-mass spectrometry. The antifungal efficacy of nanohexaconazole (N-hexa) was studied in vitro, compared with micronised hexaconazole (M-hexa) at different doses (5 ppm, 10 ppm and control) against two food pathogenic fungi: Aspergillus niger (MTCC 282, MTCC 2196 and BDS 113) and Aspergillus fumigatus through poisoned food technique. A dose-dependent significant growth inhibition was observed in nanohexaconazole (N-hexa) treated fungal sample compared with that of micronised hexaconazole (M-hexa). Micrographic studies for the morphological analysis of control and nanohexaconazole (N-hexa) treated fungal samples were done, exhibited an alternation in fungal morphology. Results showed that nanohexaconazole (N-hexa) is more efficacious than commercially available micronised hexaconazole (M-hexa). In future nanohexaconazole (N-hexa) could be a possible candidate for modern medical science and also reduce damage to the environment from injudicious use of pesticides.
Figures




References
-
- Sancholle M. Weete J. Montani C.: ‘Effect of triazoles on fungi. I: Growth and cellular permeability’, Pest. Biochem. Physiol., 1984, 21, (1), pp. 31 –44
-
- Premkumar R. Baby U.I.: ‘Blister blight control – a review of current recommendation’, Planter's Chronicle, 2005, 101, (5), pp. 26 –36
-
- Maertens J.A. Boogaerts M.A.: ‘Fungal cell wall inhibitors: emphasis on clinical aspects’, Current Pharm. Des., 2000, 6, (2), pp. 225 –239 (15) - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources